These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26423085)

  • 1. On the evolutionary advantage of coagulation factor V Leiden (FVL).
    Lindqvist PG
    Curr Med Chem; 2015; 22(32):3676-81. PubMed ID: 26423085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carriership of Factor V Leiden and evolutionary selection advantage.
    Lindqvist PG; Dahlbäck B
    Curr Med Chem; 2008; 15(15):1541-4. PubMed ID: 18537629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
    Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
    Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
    Tzoran I; Papadakis E; Brenner B; Valle R; López-Jiménez L; García-Bragado F; Riera-Mestre A; Villalobos A; Quintavalla R; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S11-S15. PubMed ID: 28262227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden paradox in a middle-aged Swedish population: A prospective study.
    Zöller B; Melander O; Svensson PJ; Engström G
    Vasc Med; 2018 Feb; 23(1):52-59. PubMed ID: 29320959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation.
    Tormene D; Grandone E; De Stefano V; Tosetto A; Palareti G; Margaglione M; Castaman G; Rossi E; Ciminello A; Valdrè L; Legnani C; Tiscia GL; Bafunno V; Carraro S; Rodeghiero F; Simioni P
    Thromb Haemost; 2012 Mar; 107(3):477-84. PubMed ID: 22273731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation.
    Schambeck CM; Eberl E; Geisen U; Grossmann R; Keller F
    Thromb Haemost; 2001 May; 85(5):782-6. PubMed ID: 11372668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
    Sveinsdottir SV; Saemundsson Y; Isma N; Gottsäter A; Svensson PJ
    Thromb Res; 2012 Sep; 130(3):467-71. PubMed ID: 22512897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of factor V Leiden with various clinical patterns of venous thromboembolism-the factor V Leiden paradox.
    Hirmerova J; Seidlerova J; Subrt I
    QJM; 2014 Sep; 107(9):715-20. PubMed ID: 24633260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thrombotic risk in family members of unselected individuals with factor V Leiden.
    Lensen RP; Bertina RM; de Ronde H; Vandenbroucke JP; Rosendaal FR
    Thromb Haemost; 2000 Jun; 83(6):817-21. PubMed ID: 10896231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden is associated with increased sperm count.
    van Mens TE; Joensen UN; Bochdanovits Z; Takizawa A; Peter J; Jørgensen N; Szecsi PB; Meijers JCM; Weiler H; Rajpert-De Meyts E; Repping S; Middeldorp S
    Hum Reprod; 2017 Nov; 32(11):2332-2339. PubMed ID: 28927238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sperm count may account for high population frequency of factor V Leiden.
    Cohn DM; Repping S; Büller HR; Meijers JC; Middeldorp S
    J Thromb Haemost; 2010 Mar; 8(3):513-6. PubMed ID: 20002540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-specific association of the factor V Leiden mutation with fertility and fecundity in a historic cohort. The Leiden 85-Plus Study.
    van Dunné FM; de Craen AJ; Heijmans BT; Helmerhorst FM; Westendorp RG
    Hum Reprod; 2006 Apr; 21(4):967-71. PubMed ID: 16439508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
    Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study.
    Nurk E; Tell GS; Refsum H; Ueland PM; Vollset SE
    QJM; 2006 May; 99(5):289-98. PubMed ID: 16613994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of factor V Leiden.
    Campello E; Spiezia L; Simioni P
    Expert Rev Hematol; 2016 Dec; 9(12):1139-1149. PubMed ID: 27797270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of venous thromboembolism in first-degree relatives of patients with venous thromboembolism who have factor V Leiden.
    Couturaud F; Kearon C; Leroyer C; Mercier B; Abgrall JF; Le Gal G; Lacut K; Oger E; Bressollette L; Ferec C; Lamure M; Mottier D;
    Thromb Haemost; 2006 Dec; 96(6):744-9. PubMed ID: 17139368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.